2018
DOI: 10.1080/03009742.2018.1520294
|View full text |Cite
|
Sign up to set email alerts
|

Increased expression of the proprotein convertase enzyme FURIN in rheumatoid arthritis

Abstract: FURIN is a proprotein convertase enzyme that inhibits the pro-inflammatory function of T cells and myeloid cells. Previously, elevated FURIN expression levels have been reported in immune-mediated diseases, such as primary Sjögren's syndrome. Here, we investigated the levels of FURIN in peripheral blood (PB) and synovial fluid (SF) leukocytes from patients with rheumatoid arthritis (RA). Methods FURIN mRNA expression in PB and SF cells was determined by qRT-PCR and FURIN plasma levels were measured using ELISA… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 14 publications
0
6
0
Order By: Relevance
“…Furin and other PCs process a large number of precursor proteins, such as hormones, neuropeptides, growth factors and their receptors, bacterial toxins, and adhesion molecule, through various secretory pathways (Seidah and Prat, 2012). Thus, the deregulation of FURIN is correlated with a variety of pathological conditions, including cardiovascular disease (Yakala et al, 2019), rheumatoid disease (Valli et al, 2019), endocrinopathies (Al Rifai et al, 2017), and central nervous system disorder (Yang et al, 2018). As for cancers, several studies have found that FURIN is expressed in various cancers and sarcomas (Khatib et al, 2002;Coppola et al, 2008;Lee et al, 2016;Jaaks and Bernasconi, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Furin and other PCs process a large number of precursor proteins, such as hormones, neuropeptides, growth factors and their receptors, bacterial toxins, and adhesion molecule, through various secretory pathways (Seidah and Prat, 2012). Thus, the deregulation of FURIN is correlated with a variety of pathological conditions, including cardiovascular disease (Yakala et al, 2019), rheumatoid disease (Valli et al, 2019), endocrinopathies (Al Rifai et al, 2017), and central nervous system disorder (Yang et al, 2018). As for cancers, several studies have found that FURIN is expressed in various cancers and sarcomas (Khatib et al, 2002;Coppola et al, 2008;Lee et al, 2016;Jaaks and Bernasconi, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…In our study, no correlation was observed between FURIN and disease activity in RA patients; this is consistent with a current research suggesting that FURIN levels in peripheral blood were not associated with ESR and CRP. Valli et al18 demonstrated that elevated FURIN expression indicated the severity of RA and that the FURIN levels positively correlate with prednisolone treatment. However, we found that the levels of FURIN in the prednisolone treatment group were relatively lower but with no statistic difference(Table S2).…”
mentioning
confidence: 99%
“…Altered expression levels of FURIN have been associated with human malignancies including lung and skin cancers [5,6] as well as with autoimmune diseases such as Sjögren's syndrome and rheumatoid arthritis [37,38]. In fact, cell therapy where a combination of granulocyte-macrophage colony stimulating factor (GMCSF) cDNA and a shRNA construct against FURIN (Vigil, Gradalis) are transfected into autologous tumor cells is currently being evaluated in phase I-III clinical trials against human gyneco- In panels (A) and (C), the statistical evaluation of differences was done using DESeq2 and adjusted using the Benjamini-Hochberg method.…”
Section: Discussionmentioning
confidence: 99%